UBS Maintains Buy on Option Care Health, Lowers Price Target to $39
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst A.J. Rice maintains Option Care Health (NASDAQ:OPCH) with a Buy and lowers the price target from $45 to $39.
UBS analyst A.J. Rice maintains Option Care Health (NASDAQ:OPCH) with a Buy and lowers the price target from $45 to $39.